Subtype
Large Intestinal Neoplasm
CI-CAN-00001062Explore in graph →
Non-malignant1,847 active trials21 approved drugs383 evidence items
- NCIt
- C215201
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001062Explore in graph →
Clinical trials
8,849 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05667181 | The Application Value of da Vinci Linear Cutting Stapler SureForm in Robotic Anus Preserving Surgery for Rectal Cancer | completed | N/A | 276 | Nanchang UniversityOTHER | 1 | May 28, 2025 | clinicaltrials |
| NCT05801965 | A Digital Therapeutic Solution for Cancer Patients | completed | N/A | 48 | Sidekick HealthINDUSTRY | 1 | May 25, 2025 | clinicaltrials |
| NCT03206151 |
| CMAB009 Combined With FOLFIRI First-line Treatment in Patients With RAS/BRAF Wild-type, Metastatic Colorectal Cancer |
| completed |
| Phase 3 |
| 520 |
| Taizhou Mabtech Pharmaceutical Co.,LtdINDUSTRY |
| 1 |
| May 23, 2025 |
| clinicaltrials |
| NCT06804876 | COMBO Endoscopy Oropharyngeal Airway in Sedated Gastrointestinal Endoscopy for Obese Patients | completed | Phase 2 | 107 | Zhejiang UniversityOTHER | 1 | May 21, 2025 | clinicaltrials |
| NCT04121286 | A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in China | completed | Phase 1 | 17 | Allist Pharmaceuticals, Inc.INDUSTRY | 1 | May 20, 2025 | clinicaltrials |
| NCT02138617 | Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer | completed | Phase 2 | 100 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 18, 2025 | clinicaltrials |
| NCT06978595 | Primary Colorectal Signet Ring Cell Carcinoma and the Risk of Multiple Primary Gastrointestinal Malignancies | completed | — | 8,171 | asmaa salama ibrahimOTHER | 1 | May 18, 2025 | clinicaltrials |
| NCT02380443 | AlloStim® Immunotherapy Dosing Alone or in Combination With Cryoablation in Metastatic Colorectal Cancer | completed | Phase 2 | 13 | Mirror Biologics, Inc.INDUSTRY | 1 | May 16, 2025 | clinicaltrials |
| NCT04449679 | Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study | completed | N/A | 34 | Thomas Jefferson UniversityOTHER | 1 | May 15, 2025 | clinicaltrials |
| NCT06324097 | Diagnostic Value of Endocytoscopy for Colorectal Lesions | completed | — | 463 | Hong XuOTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT03867409 | The United States Healthy Living Study | completed | N/A | 2,105 | University of FloridaOTHER | 1 | May 13, 2025 | clinicaltrials |
| NCT05658263 | Bacterial Intestinal Gut Modification Around Cancer Surgery (BIG MACS) Diet | completed | Early Phase 1 | 14 | University of MinnesotaOTHER | 1 | May 13, 2025 | clinicaltrials |
| NCT06957574 | Erector Spinae Plane Block as Analgesia in Patients for Colectomy | completed | N/A | 60 | Suez Canal UniversityOTHER | 1 | May 13, 2025 | clinicaltrials |
| NCT00574353 | Study Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography to Detect Hypoxia in Locally Advanced (T3-T4 and./or N1)Primary Rectal Cancer Patients | completed | N/A | 23 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 9, 2025 | clinicaltrials |
| NCT03407417 | A Patient-centered Intervention Using Technology to Reduce Colorectal Cancer Disparities in Primary Care | completed | N/A | 960 | University of FloridaOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT06137248 | Study to Assess Colonic Microbiota Changes in Response to Energy Drink Consumption(ROSANNA) | completed | Phase 2 | 76 | University of FloridaOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT02272244 | Increasing Colorectal Cancer (CRC) Screening Among Hispanic Primary Care Patients | completed | N/A | 400 | Thomas Jefferson UniversityOTHER | 1 | May 4, 2025 | clinicaltrials |
| NCT06124131 | Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening(BENEFIT-C) | completed | N/A | 50 | Tulane UniversityOTHER | 1 | May 4, 2025 | clinicaltrials |
| NCT01972737 | Phase I Study of Ad5-hGCC (Human Guanylyl Cyclase C)-PADRE in Stage I/II Colon Cancer | completed | Phase 1 | 10 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | May 2, 2025 | clinicaltrials |
| NCT02632448 | A Study of LY2880070 in Participants With Advanced or Metastatic Cancer | completed | Phase 1 / Phase 2 | 229 | Esperas Pharma Inc.OTHER | 4 | May 2, 2025 | clinicaltrials |
| NCT04328740 | Phase 1 Study of Oral TP-1454 | completed | Phase 1 | 31 | Sumitomo Pharma America, Inc.INDUSTRY | 1 | May 1, 2025 | clinicaltrials |
| NCT04495621 | MEN1611 With Cetuximab in Metastatic Colorectal Cancer (C-PRECISE-01)(C-PRECISE-01) | completed | Phase 1 / Phase 2 | 29 | Menarini GroupINDUSTRY | 7 | May 1, 2025 | clinicaltrials |
| NCT06573424 | Tirellizumab+Anlotinib VS Anlotinib for MSS-type CRC | completed | — | 124 | fan liOTHER | 1 | May 1, 2025 | clinicaltrials |
| NCT06950996 | A Clinical Evaluation of AI Solutions Developed in the CHAIMELEON Project for Cancer: Prostate, Lung, Breast, Colon and Rectum | completed | — | 300 | Instituto de Investigacion Sanitaria La FeOTHER | 1 | Apr 30, 2025 | clinicaltrials |
| NCT04468607 | A Study of BLYG8824A in Participants With Locally Advanced or Metastatic Colorectal Cancer | completed | Phase 1 | 46 | Genentech, Inc.INDUSTRY | 3 | Apr 25, 2025 | clinicaltrials |
| NCT04491955 | Phase II Trial of Combination Immunotherapy in Subjects With Advanced Small Bowel and Colorectal Cancers | completed | Phase 2 | 32 | National Cancer Institute (NCI)NIH | 1 | Apr 24, 2025 | clinicaltrials |
| NCT03428958 | A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment | completed | Phase 1 / Phase 2 | 111 | NuCana plcOTHER | 3 | Apr 23, 2025 | clinicaltrials |
| NCT04705363 | A Sociolinguistic-enabled Web Application to Develop Precision Health Intervention for African Americans | completed | N/A | 751 | University of FloridaOTHER | 1 | Apr 18, 2025 | clinicaltrials |
| NCT05500248 | Artificial Intelligence for Leaving in Situ Colorectal Polyps. | completed | N/A | 919 | University of Roma La SapienzaOTHER | 1 | Apr 18, 2025 | clinicaltrials |
| NCT02934529 | Metastatic Colorectal Cancer (RAS-wildtype) After Response to First-line Treatment With FOLFIR Plus Cetuximab(AIO-KRK-0114) | completed | Phase 3 | 673 | Ludwig-Maximilians - University of MunichOTHER | 1 | Apr 16, 2025 | clinicaltrials |
| NCT02990481 | A Phase 1 Study Evaluating the Safety of TRK-950 in Patients With Advanced Solid Tumors | completed | Phase 1 | 38 | Toray Industries, IncINDUSTRY | 2 | Apr 16, 2025 | clinicaltrials |
| NCT06324409 | ImmigrantScreen Telephone Reminder Trial in Colorectal Cancer Screening | completed | N/A | 400 | Norwegian Institute of Public HealthOTHER_GOV | 1 | Apr 15, 2025 | clinicaltrials |
| NCT04441580 | Assessing the Additional Neoplasia Yield of Computer-aided Colonoscopy in a Screening Setting(GENIAL-CO) | completed | N/A | 900 | Fondazione Poliambulanza Istituto OspedalieroOTHER | 1 | Apr 10, 2025 | clinicaltrials |
| NCT06910514 | Efficacy and Safety of a Solution for Endoscopic Mucosal Resection of Colonic Lesions | completed | Phase 3 | 52 | Nakafarma S.L.INDUSTRY | 1 | Apr 9, 2025 | clinicaltrials |
| NCT04566614 | Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies(PREVAILctDNA) | completed | — | 128 | Royal Marsden NHS Foundation TrustOTHER | 1 | Apr 6, 2025 | clinicaltrials |
| NCT04322539 | A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer(FRESCO-2) | completed | Phase 3 | 691 | Hutchison Medipharma LimitedINDUSTRY | 14 | Apr 4, 2025 | clinicaltrials |
| NCT04582500 | Virtual Colonoscopy Using Omnipaque as a Contrast Agent | completed | — | 50 | Montefiore Medical CenterOTHER | 1 | Apr 4, 2025 | clinicaltrials |
| NCT03597581 | A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer | completed | Phase 1 | 89 | Inspirna, Inc.INDUSTRY | 1 | Apr 3, 2025 | clinicaltrials |
| NCT05255588 | A Stool DNA-based SDC2 Methylation Test for the Early Detection of Colorectal Cancer | completed | — | 2,358 | Genomictree, Inc.INDUSTRY | 1 | Apr 3, 2025 | clinicaltrials |
| NCT03894618 | SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas | completed | Phase 1 | 49 | Shattuck Labs, Inc.INDUSTRY | 4 | Apr 2, 2025 | clinicaltrials |
| NCT05742438 | Effects of Dexmedetomidine/Lidocaine/Intrathecal Morphine on Cancer Metastasis Biomarker After Colorectal Surgery | completed | N/A | 114 | Samsung Medical CenterOTHER | 1 | Apr 2, 2025 | clinicaltrials |
| NCT04761614 | Riluzole in Combination With mFOLFOX6 and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 1 | 13 | Ning JinOTHER | 1 | Mar 28, 2025 | clinicaltrials |
| NCT05390398 | Study on Fatigue in Colorectal Cancer Survivors, a Lifestyle Intervention(SoFiT) | completed | N/A | 161 | Wageningen UniversityOTHER | 1 | Mar 28, 2025 | clinicaltrials |
| NCT06900686 | Clinical Application of PD-1 Inhibitor in Colorectal Cancer for Improving Survival | completed | — | 458 | Yanhong DengOTHER | 0 | Mar 28, 2025 | clinicaltrials |
| NCT03506321 | Comparison of the Benefit of Chromoendoscopy in Addition to High Definition White Light and Narrow Band Imaging for the Prediction of Submucosal Invasive Cancer in Colonic Lesions(LANS) | completed | N/A | 400 | Western Sydney Local Health DistrictOTHER | 1 | Mar 27, 2025 | clinicaltrials |
| NCT04138030 | Conventional Endoscopic Mucosal Resection Versus Cold Snare Endoscopic Mucosal Resection of Colonic Lateral Spreading Lesions - A Randomised Controlled Trial | completed | N/A | 182 | Western Sydney Local Health DistrictOTHER | 1 | Mar 27, 2025 | clinicaltrials |
| NCT06898359 | Role of Gut Microbiota in Neoadjuvant Radioimmunotherapy for MSS, Locally Advanced Rectal Cancer | completed | — | 29 | Yanhong DengOTHER | 1 | Mar 27, 2025 | clinicaltrials |
| NCT00059930 | Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer | completed | Phase 1 | 38 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 26, 2025 | clinicaltrials |
| NCT02882620 | Enhancing Prevention Pathways Toward Tribal Colorectal Health | completed | N/A | 1,788 | University of New MexicoOTHER | 1 | Mar 25, 2025 | clinicaltrials |
Data updated 24 days agoSource updated May 28, 2025source: clinicaltrials